Le Lézard
Classified in: Science and technology
Subject: IPO

Astera Labs Announces Pricing of Initial Public Offering


Astera Labs, Inc. ("Astera Labs") today announced the pricing of its initial public offering of 19,800,000 shares of its common stock at a price to the public of $36.00 per share. The offering consists of 16,788,903 shares of common stock offered by Astera Labs and 3,011,097 shares of common stock to be sold by certain of Astera Labs' existing stockholders.

In addition, the underwriters will have a 30-day option to purchase up to an additional 2,970,000 shares of common stock from Astera Labs at the initial public offering price, less underwriting discounts and commissions. The gross proceeds to Astera Labs from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Astera Labs, are expected to be approximately $604.4 million. Astera Labs will not receive any proceeds from the sale of shares by the selling stockholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol "ALAB" on March 20, 2024. The offering is expected to close on March 22, 2024, subject to customary closing conditions.

Morgan Stanley and J.P. Morgan are acting as joint book runners for the offering. Barclays, Deutsche Bank Securities, Evercore ISI and Jefferies are additionally acting as book runners, and Needham & Company, Stifel, Craig-Hallum Capital Group, Roth Capital Partners, Loop Capital Markets and Siebert Williams Shank are acting as co-managers.

The proposed offering will be made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014 and J.P. Morgan Securities LLC, Attn: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by toll free telephone at 1-866-803-9204 or by email at [email protected].

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission, and became effective on March 19, 2024. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Astera Labs

Astera Labs is a global leader in purpose-built connectivity solutions that unlock the full potential of AI and cloud infrastructure. Our Intelligent Connectivity Platform integrates PCIe®, CXL®, and Ethernet semiconductor-based solutions based on a software-defined architecture that is both scalable and customizable. Inspired by trusted relationships with hyperscalers and the data center ecosystem, we are an innovation leader delivering products that are flexible and interoperable. Discover how we are transforming modern data-driven applications at www.asteralabs.com.


These press releases may also interest you

at 10:33
The Software Development Conference 2024 (SDCon), co-organised by CSDN and Boolan, a high-end IT consulting and education platform, will be held at the Westin Beijing on 4-5 July, and will continue to deliver substantive content through real-world...

at 10:31
According to a new market research report titled, 'Public Safety and Security Market by Offering (Safety Devices, Safety Software, Safety Services), Technology (IoT, AI, Cloud Computing, ML), Application (Data Gathering, Mapping, and 3D Imaging), End...

at 10:30
Communications Data Group (CDG) is pleased to announce the upcoming launch of its newly named OSS/BSS platform, Elements, for managing and invoicing subscriber, enterprise, wholesale, and carrier services. The Elements platform unifies all the...

at 10:20
Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI). The goal of this Phase 2 SPI-1005...

at 10:20
SecurityScorecard has been named a leader in The Forrester WaveTM: Cybersecurity Risk Ratings Platforms, Q2 2024. The report covers 10 vendors with cybersecurity risk ratings capabilities. SecurityScorecard received the highest score possible across...

at 10:19
Shared market leadership underscores strong partnership in Edge AI applications The Quadrant Knowledge Solutions SPARK Matrixtm provides competitive analysis and ranking of the leading Internet of Things (IoT) edge analytics platform...



News published on and distributed by: